Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy

Infiltration (HVAC) Cancer Immunotherapy Immunogenic cell death Chemoimmunotherapy
DOI: 10.1126/sciadv.aaz9240 Publication Date: 2020-05-15T23:59:07Z
ABSTRACT
CXCR4 antagonistic nanocomplex regulates the immune process to enhance anti–PD-L1 immunotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (131)